Cancer Vaccine Articles & Analysis
22 articles found
As the fight against cancer progresses, there is an increasing demand for novel and personalized therapeutic approaches. ...
Alfa Cytology has unveiled new services focused on therapeutic antibody development for bladder cancer research.Alfa Cytology, a prominent cancer research services supplier based in New York, proudly announces the launch of its comprehensive services for bladder cancer therapeutic antibody development. ...
In recent years, messenger RNA (mRNA) technology has emerged as a revolutionary approach in the field of medicine, particularly in vaccine development and gene therapy. The ability to deliver mRNA effectively to target cells is crucial for harnessing its potential in treating a variety of diseases, including infectious diseases, cancer, and genetic disorders. ...
Notable examples include peptide hormones like insulin and drugs used in cancer treatment. Vaccines Synthetic peptides are employed in the development of vaccines, providing a safe and stable alternative to traditional attenuated or inactivated pathogens. Peptide-based vaccines are designed to elicit specific immune responses, ...
The COVID-19 pandemic opened the floodgates for mRNA research and applications, showing the world how critical mRNA technology can be. Remember those mRNA vaccines? They were developed at unprecedented speed, thanks to the work of enzymes that enabled the rapid and large-scale production of mRNA. Pfizer-BioNTech and Moderna utilized advanced enzymatic processes to generate ...
Additionally, to delve deeper into cancer pathogenesis, Alfa Cytology also provides in vivo and in vitro cancer model customization services, providing versatile models that simulate diverse cancer types and stages. ...
Cancer vaccines are designed to stimulate the immune system to recognize and attack cancer cells, analogous to how traditional vaccines work against infectious diseases. The development principle of cancer vaccines usually includes the identification of antigens, vaccine ...
Alfa Cytology has announced pancreatic cancer vaccine development services to improve the efficacy and safety of related vaccines. Alfa Cytology, a biotech company composed of scientists, bioinformatics, and oncologists, has recently announced its pancreatic cancer vaccine development services to provide ...
Antimicrobial peptides also demonstrate anti-inflammatory, anti-cancer, and wound healing properties, broadening their portfolio of potential applications. ...
Functional assays are also used as potency biomarkers for cancer vaccine potency evaluation. ...
Polyactin A, a synthetic peptide with multiple arginine residues, has been used as an effective adjuvant for peptide cancer vaccines. The most common carbohydrates and derivatives used as adjuvants include mannose, glucan, chitosan, hyaluronic acid, saponins, alpha-galactosylceramide, and the polymerized form of muramyl dipeptide (MDP).Peptide ...
Cytokines-mediated signaling is a primary way of immune system communication. The common gamma-chain family of cytokines is a set of six cytokines that signal through the common cytokine γ chain receptor (γc/CD132/IL2RG). These cytokines include IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Besides the IL-2RG receptor subunit, the γc family cytokine receptors include IL-2RB ...
Many cell and gene therapy solutions have shown considerable promise as a source of possible treatments for a wide range of chronic disorders. However, these sophisticated therapies introduce additional barriers such as the requirements for ultra-low and cryogenic storage, which affect numerous steps of the biomedical solutions’ life cycles, from their development to their administration. ...
Vaccine remains the most effective source of defense against the COVID-19 pandemic since 2020. The success of the lipid nanoparticle COVID-19 mRNA vaccine shows that nanotechnology can be used in vaccine development. ...
Studying the vaccine in dogs could provide insight into its effectiveness in people What if someone told you that a vaccine shot could prevent you from getting multiple types of cancer—ones as different from each other as breast cancer and lymphoma? ...
ByCalviri
Calviri, a company founded by Stephen Johnston, a professor at ASU and the director at the Biodesign Center for Innovations in Medicine, is developing a preventive cancer vaccine in the heart of Phoenix. Startup companies in Phoenix are looking for young professionals who can bring new ideas to the table, to help the industry grow exponentially, Johnston said. ...
ByCalviri
Therapeutic vaccines may well be the next wave of immunotherapy for cancer treatment. Peptide-based vaccines will play a pivotal role in the field. How is a peptide vaccine designed? ...
LONDON, June 28, 2021 (GLOBE NEWSWIRE) – Treos Bio Limited (“Treos”), a clinical stage biotechnology company using data science and proprietary biomarkers to develop precision off-the-shelf and personalized peptide cancer immunotherapies, today announced the publication of a peer-reviewed article titled “A Peptide Vaccine Candidate ...
Cervical cancer is the second most common cancer affecting and causing deaths among women in India. ...
However, these designs are poorly applicable for the development of cancer therapeutic vaccines because the expected safety concerns for these vaccines are not as much as cytotoxic agents. The primary objectives of a cancer therapeutic vaccine phase I trial thus often include determining whether the ...